Last updated on May 2020

A Registry Study to Observe Clinical Outcomes of Participants With High-risk Metastatic Hormone-na ve Prostate Cancer in Japan


Brief description of study

The purpose of this registry study is to longitudinally observe clinical outcomes and patient-reported outcomes (PRO) for participants with high-risk metastatic hormone-naive prostate cancer (mHNPC) in the real-world setting in Japan.

Clinical Study Identifier: NCT04034095

Find a site near you

Start Over